NPPB and hydrops fetalis: This systematic review examined the utility of NT-proBNP as a prognostic biomarker for predicting hospital readmissions in patients with HF, synthesizing evidence from six diverse studies encompassing randomized controlled trials, cohort studies, and observational designs.